Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PALVELLA THERAPEUTICS, INC. | 12,350 | reported | 10 Jun 2025 | tx 17+367,550−5,000 |
| HTG MOLECULAR DIAGNOSTICS, INC | 4,000 | reported | 15 Sept 2022 | tx 2+12,000 |
| KOS PHARMACEUTICALS INC | 3,000 | reported | 15 Mar 2004 | tx 21+215,000−63,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Jun 2025 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 12,350 | 0.00 USD | deriv |
| 13 Dec 2024 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 24,700 | 0.00 USD | deriv |
| 02 Dec 2024 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 500 | 0.00 USD | deriv |
| 21 Jun 2023 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 40,000 | 0.00 USD | deriv |
| 25 May 2023 | PURCHASE | PALVELLA THERAPEUTICS, INC. | 10,000 | 0.85 USD | first after silence |
| 15 Sept 2022 | GRANT_AWARD | HTG MOLECULAR DIAGNOSTICS, INC | 4,000 | 0.00 USD | deriv |
| 22 Jun 2022 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 40,000 | 0.00 USD | deriv |
| 27 Jan 2022 | GRANT_AWARD | HTG MOLECULAR DIAGNOSTICS, INC | 8,000 | 0.00 USD | deriv |
| 25 Jun 2021 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 40,000 | 0.00 USD | deriv |
| 23 Jun 2020 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 40,000 | 0.00 USD | deriv |
| 25 Jan 2020 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 20,000 | 0.00 USD | deriv |
| 25 Jan 2019 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 20,000 | 0.00 USD | deriv |
| 14 Sept 2018 | PURCHASE | PALVELLA THERAPEUTICS, INC. | 5,000 | 5.11 USD | |
| 25 Jan 2018 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 20,000 | 0.00 USD | deriv |
| 21 Apr 2017 | EXERCISE | PALVELLA THERAPEUTICS, INC. | 5,000 | 1.59 USD | |
| 21 Apr 2017 | EXERCISE | PALVELLA THERAPEUTICS, INC. | 5,000 | 0.00 USD | deriv |
| 25 Jan 2017 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 20,000 | 0.00 USD | deriv |
| 20 Sept 2016 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 30,000 | 0.00 USD | deriv |
| 12 Mar 2004 | EXERCISE | KOS PHARMACEUTICALS INC | 5,000 | 5.06 USD | |
| 12 Mar 2004 | SALE | KOS PHARMACEUTICALS INC | 5,000 | 43.42 USD | |
| 15 Mar 2004 | EXERCISE | KOS PHARMACEUTICALS INC | 3,000 | 5.06 USD | |
| 15 Mar 2004 | EXERCISE | KOS PHARMACEUTICALS INC | 2,000 | 5.75 USD | |
| 15 Mar 2004 | SALE | KOS PHARMACEUTICALS INC | 5,000 | 42.04 USD | |
| 12 Mar 2004 | EXERCISE | KOS PHARMACEUTICALS INC | 5,000 | 0.00 USD | deriv |
| 15 Mar 2004 | EXERCISE | KOS PHARMACEUTICALS INC | 3,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 25 May 2023.